These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26486143)

  • 1. siRNA Delivery by Stimuli-Sensitive Nanocarriers.
    Salzano G; Costa DF; Torchilin VP
    Curr Pharm Des; 2015; 21(31):4566-73. PubMed ID: 26486143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
    Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
    Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-Responsive Nanoparticles for siRNA Delivery.
    Eloy JO; Petrilli R; Lopez RF; Lee RJ
    Curr Pharm Des; 2015; 21(29):4131-44. PubMed ID: 26323434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
    Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR
    Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
    Kozielski KL; Rui Y; Green JJ
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-sensitive nanopreparations for combination cancer therapy.
    Jhaveri A; Deshpande P; Torchilin V
    J Control Release; 2014 Sep; 190():352-70. PubMed ID: 24818767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
    Zhang P; An K; Duan X; Xu H; Li F; Xu F
    Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
    Kriegel C; Attarwala H; Amiji M
    Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attacking the genome: emerging siRNA nanocarriers from concept to clinic.
    Alabi C; Vegas A; Anderson D
    Curr Opin Pharmacol; 2012 Aug; 12(4):427-33. PubMed ID: 22726555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
    Mehrotra N; Tripathi RM
    IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
    Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
    Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-viral Delivery Systems for Breast Cancer Gene Therapy.
    Vaseghi G; Rafiee L; Javanmard SH
    Curr Gene Ther; 2017; 17(2):147-153. PubMed ID: 28595562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.